Medtronic, Inc. has just submitted the final pre-market approval documents to the FDA for its Talent™ Thoracic Stent Graft System. At the present time there is no evidence to expect that the FDA would create any hurdles for the company to commercially market and sell its endovascular system for descending thoracic aneurysms. From the press release: Minimally […]

Newly approved implantable defibrillator from St. Jude Medical, in addition to shocking, also has an anti-atrial fibrillation functionality: The Atlas® II+ HF CRT-D (cardiac resynchronization therapy defibrillator) is the first U.S. heart failure device to offer the AF Suppression™ algorithm. This proprietary algorithm helps maintain control of the heart’s atrial rhythm by pacing slightly faster […]